Latest filing published 19 Jan 2021 for Viking Therapeutics, Inc., €9,320.
Michael Morneau appears in our data through filings on Viking Therapeutics, Inc. shares, published by SEC (Form 4). In total, 12 filings cover trades dated from 4 May 2017 to 19 January 2021.
The open-market record consists of 1 sale worth €170k, with no purchase. Besides market trades, the filings include 11 share grants.
Most recently, on 19 January 2021, the filings show a share grant worth €9,320 in Viking Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations